EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complex

EGFR-targeted therapy in head and neck squamous cell carcinoma (HNSCC) patients frequently results in tumor resistance to treatment. Autophagy is an emerging underlying resistance mechanism, however, the molecular autophagy machinery in HNSCC cells and potential biomarkers of patient response to EGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yu, Kansy, Benjamin A., Li, Jing, Cong, Linhai, Liu, Yang, Trivedi, Sumita, Wen, Haitao, Ting, Jenny P.-Y., Ouyang, Hongjiao, Ferris, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257174/
https://www.ncbi.nlm.nih.gov/pubmed/26876213
http://dx.doi.org/10.1038/onc.2016.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257174/
https://www.ncbi.nlm.nih.gov/pubmed/26876213
http://dx.doi.org/10.1038/onc.2016.11

Ejemplares similares